DIFFERENTIATION STATE AND INVASIVENESS OF HUMAN BREAST-CANCER CELL-LINES

被引:257
|
作者
SOMMERS, CL
BYERS, SW
THOMPSON, EW
TORRI, JA
GELMANN, EP
机构
[1] GEORGETOWN UNIV,VINCENT T LOMBARDI CANC RES CTR,WASHINGTON,DC 20007
[2] GEORGETOWN UNIV,DEPT CELL BIOL,WASHINGTON,DC 20007
关键词
BREAST CANCER; VIMENTIN; INVASION; INTEGRINS; CADHERINS; EPITHELIAL;
D O I
10.1007/BF00666165
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Eighteen breast cancer cell lines were examined for expression of markers of epithelial and fibroblastic differentiation: E-cadherin, desmoplakins, ZO-1, vimentin, keratin and beta(1) and beta(4) integrins. The cell lines were distributed along a spectrum of differentiation from epithelial to fibroblastic phenotypes. The most well-differentiated, epithelioid cell lines contained proteins characteristic of desmosomal, adherens and tight junctions, were adherent to one another on plastic and in the basement membrane matrix Matrigel and were keratin-positive and vimentin-negative. These cell lines were all weakly invasive in an in vitro chemoinvasion assay. The most poorly-differentiated, fibroblastic cell lines were E-cadherin-, desmoplakin- and ZO-1-negative and formed branching structures in Matrigel. They were vimentin-positive, contained only low levels of keratins and were highly invasive in the in vitro chemoinvasion assay. Of all of the markers analyzed, vimentin expression correlated best with in vitro invasive ability and fibroblastic differentiation. In a cell line with unstable expression of vimentin, T47D(CO), the cells that were invasive were of the fibroblastic type. The differentiation markers described here may be useful for analysis of clinical specimens and could potentially provide a more precise measure of differentiation grade yielding more power for predicting prognosis.
引用
收藏
页码:325 / 335
页数:11
相关论文
共 50 条
  • [31] PROLACTIN RECEPTOR ANTAGONISTS THAT INHIBIT THE GROWTH OF BREAST-CANCER CELL-LINES
    FUH, G
    WELLS, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) : 13133 - 13137
  • [32] GENETIC AND IMMUNOCHEMICAL ANALYSIS OF MUTANT P53 IN HUMAN BREAST-CANCER CELL-LINES
    BARTEK, J
    IGGO, R
    GANNON, J
    LANE, DP
    [J]. ONCOGENE, 1990, 5 (06) : 893 - 899
  • [33] GENERATION OF HUMAN ANTIBODY-SECRETORY CELL-LINES FROM LYMPHOCYTES OF BREAST-CANCER PATIENTS
    BRENNER, BG
    MARGOLESE, RG
    [J]. HYBRIDOMA, 1984, 3 (01): : 69 - 69
  • [34] AUTOLOGOUS AND HOMOLOGOUS IMMUNOFLUORESCENT ANTIBODY TO ESTABLISHED BREAST-CANCER CELL-LINES
    WISEMAN, C
    CAILLEAU, R
    OLIVE, M
    BLUMENSCHEIN, GR
    BOWEN, JM
    [J]. IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1980, 16 (07): : 629 - 633
  • [35] ESTROGEN-RECEPTOR DISTRIBUTION IN ENUCLEATED BREAST-CANCER CELL-LINES
    WELSHONS, WV
    CORMIER, EM
    WOLF, MF
    WILLIAMS, PO
    JORDAN, VC
    [J]. ENDOCRINOLOGY, 1988, 122 (06) : 2379 - 2386
  • [36] EFFECTS OF ESTROGEN AND ANTIESTROGEN ON THE MORPHOLOGY OF SENSITIVE BREAST-CANCER CELL-LINES
    ZIPPEL, HH
    HACKENBERG, R
    KLEIN, PJ
    HOLZEL, F
    SCHULZ, KD
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 332 - 332
  • [37] CHARACTERIZATION OF A H-3 GNRH METHOD FOR THE MEASUREMENT OF GNRH BINDING-SITES IN HUMAN BREAST-CANCER AND BREAST-CANCER CELL-LINES
    RESHKIN, SJ
    PEZZETTA, A
    ALBARANI, V
    SCHITTULLI, F
    PARADISO, A
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (02) : 371 - 375
  • [38] STEROID METABOLISM IN HUMAN BREAST-CANCER CELL LINES
    RAJU, U
    SKLAREW, RJ
    POST, J
    LEVITZ, M
    [J]. STEROIDS, 1978, 32 (05) : 669 - 680
  • [39] PRODUCTION OF HUMAN-HUMAN HYBRIDOMAS SECRETING MONOCLONAL-ANTIBODIES REACTIVE TO BREAST-CANCER CELL-LINES
    AIHARA, K
    YAMADA, K
    MURAKAMI, H
    NOMURA, Y
    OMURA, H
    [J]. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY, 1988, 24 (09): : 959 - 962
  • [40] IMMUNOREACTIVE HEPATOCYTE GROWTH-FACTOR IS PRESENT IN TISSUE-EXTRACTS FROM HUMAN BREAST-CANCER BUT NOT IN CONDITIONED MEDIUM OF HUMAN BREAST-CANCER CELL-LINES
    YAMASHITA, J
    OGAWA, M
    BEPPU, T
    [J]. RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1993, 82 (02): : 249 - 252